BARAZZONI, ROCCO
 Distribuzione geografica
Continente #
NA - Nord America 20.810
EU - Europa 15.229
AS - Asia 14.801
SA - Sud America 3.683
AF - Africa 475
OC - Oceania 176
Continente sconosciuto - Info sul continente non disponibili 27
Totale 55.201
Nazione #
US - Stati Uniti d'America 19.515
CN - Cina 4.486
SG - Singapore 3.514
IT - Italia 3.119
PL - Polonia 2.598
BR - Brasile 2.436
VN - Vietnam 1.107
SE - Svezia 1.073
HK - Hong Kong 1.064
DE - Germania 1.020
ES - Italia 994
JP - Giappone 981
MX - Messico 910
TR - Turchia 862
UA - Ucraina 855
NL - Olanda 845
FI - Finlandia 738
FR - Francia 684
KR - Corea 595
GB - Regno Unito 564
ID - Indonesia 513
IN - India 474
RU - Federazione Russa 468
AR - Argentina 369
PT - Portogallo 293
CO - Colombia 278
IE - Irlanda 274
CH - Svizzera 268
BE - Belgio 259
CA - Canada 254
BG - Bulgaria 241
GR - Grecia 194
TW - Taiwan 178
CL - Cile 175
TH - Thailandia 152
AU - Australia 147
EC - Ecuador 140
PE - Perù 137
IL - Israele 125
AT - Austria 112
DK - Danimarca 93
PH - Filippine 92
MA - Marocco 89
SA - Arabia Saudita 81
EG - Egitto 78
MY - Malesia 76
BD - Bangladesh 75
PK - Pakistan 69
RO - Romania 68
ZA - Sudafrica 66
VE - Venezuela 63
HU - Ungheria 62
SI - Slovenia 62
IQ - Iraq 60
HR - Croazia 59
IR - Iran 58
CZ - Repubblica Ceca 52
NO - Norvegia 51
PY - Paraguay 40
TN - Tunisia 40
DZ - Algeria 34
LT - Lituania 34
CR - Costa Rica 30
SN - Senegal 30
AE - Emirati Arabi Uniti 29
SK - Slovacchia (Repubblica Slovacca) 29
NZ - Nuova Zelanda 28
LV - Lettonia 27
ET - Etiopia 26
EE - Estonia 25
PA - Panama 23
NP - Nepal 22
BO - Bolivia 20
UY - Uruguay 20
KZ - Kazakistan 19
UZ - Uzbekistan 19
KE - Kenya 18
NG - Nigeria 18
CY - Cipro 17
JO - Giordania 17
RS - Serbia 17
EU - Europa 16
AZ - Azerbaigian 13
GT - Guatemala 13
MD - Moldavia 12
AL - Albania 11
HN - Honduras 11
LB - Libano 11
OM - Oman 11
SV - El Salvador 11
CM - Camerun 9
DO - Repubblica Dominicana 9
PR - Porto Rico 9
TZ - Tanzania 9
A2 - ???statistics.table.value.countryCode.A2??? 8
IS - Islanda 8
JM - Giamaica 8
LK - Sri Lanka 8
BY - Bielorussia 7
KG - Kirghizistan 7
Totale 55.038
Città #
Singapore 2.133
Warsaw 2.124
Woodbridge 1.971
Fairfield 1.759
Ashburn 1.712
Houston 1.395
Ann Arbor 1.343
San Jose 1.057
Chandler 997
Hong Kong 995
Wilmington 846
Jacksonville 779
Seattle 774
Beijing 605
Cambridge 588
Hefei 573
Trieste 552
Seoul 470
Boardman 415
Helsinki 404
Ho Chi Minh City 370
Chicago 368
Princeton 345
São Paulo 314
Hanoi 294
Milan 276
Los Angeles 272
Madrid 271
Izmir 265
Amsterdam 248
Columbus 247
Rome 246
Dublin 243
Shanghai 240
Sofia 232
Tokyo 227
Moscow 225
Lauterbourg 217
Zgierz 215
Dallas 202
Istanbul 188
The Dalles 187
Frankfurt am Main 173
Guangzhou 163
Rio de Janeiro 151
Council Bluffs 147
Ankara 136
Santa Clara 126
Bogotá 122
New York 122
Dearborn 115
Jakarta 112
Bern 107
Buenos Aires 107
Barcelona 105
Santiago 101
Athens 100
San Diego 100
Lisbon 99
Buffalo 95
Munich 92
London 90
Mexico City 88
Hangzhou 87
Redmond 87
Chengdu 86
Lima 84
Salvador 82
Amstelveen 81
Brussels 79
Belo Horizonte 77
Nanjing 77
Bangkok 76
Brasília 72
Naples 72
Valencia 70
Porto Alegre 69
Nuremberg 68
Chongqing 64
Grafing 63
Medellín 63
Curitiba 62
Chennai 61
Quito 60
Florence 59
Tianjin 59
Taipei 58
Stockholm 55
Düsseldorf 54
Guadalajara 54
Phoenix 54
Vienna 54
Bologna 53
Montreal 53
Porto 53
Tel Aviv 53
Atlanta 52
Jinan 52
Shenyang 50
Turin 50
Totale 32.038
Nome #
ESPEN guidelines on definitions and terminology of clinical nutrition 4.750
GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community 4.193
Could ketogenic diet "starve" cancer? Emerging evidence 1.568
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN 1.516
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement 1.486
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition 947
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review 616
Tuberculosis and malnutrition: The European perspective 594
Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: A review 551
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community 525
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 516
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 505
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in Rome November 2022 404
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall 400
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 399
Exposure to artificial light at night: A common link for obesity and cancer? 365
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition 361
Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress 356
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 351
Poor nutritional status but not cognitive or functional impairment per se independently predict 1 year mortality in elderly patients with hip-fracture 348
Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes 345
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 328
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 325
Nutritional status and physical inactivity in moderated asthmatics: A pilot study 321
Towards a multidisciplinary approach to understand and manage obesity and related diseases 321
Sarcopenic obesity: What about in the cancer setting? 310
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 309
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 301
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 300
n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease 286
Sarcopenic Obesity: Time to Meet the Challenge 266
Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline 265
A negative impact of recent weight loss on in-hospital mortality is not modified by overweight and obesity 260
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 258
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 255
Unacylated ghrelin improves vascular dysfunction and attenuates atherosclerosis during high-fat diet consumption in rodents 254
Nutrition in Renal Disease 253
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 248
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 246
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 246
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 238
Insulin resistance in obesity: an overview of fundamental alterations 236
A model of skeletal muscle leucine kinetics measured across the human forearm. 221
Spot-light on microbiota in obesity and cancer 220
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 218
AIWW: a new nutrition-screening tool for the oncologic population 218
Nutrition education in medical schools (NEMS). An ESPEN position paper 215
Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group 214
Multidimensional prognostic index predicts short- and long-term mortality and rehospitalizations in older patients with hip fracture 213
Acute Infusion of N-3 Polyunsaturated (N-3 PUFA) Fatty Acids is not Associated with Enhanced Reactive Oxygen Species Generation and Lowers Mitochondrial ATP Production in Rat Liver 212
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 211
Defining and diagnosing sarcopenia: Is the glass now half full? 208
PG-SGA SF in nutrition assessment and survival prediction for elderly patients with cancer 206
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 205
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 203
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group 201
The role of substrates in the regulation of protein metabolism. 192
A special thanks to the reviewers of diabetes 192
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 191
Protein degradation and synthesis measured with multiple amino acid tracers in vivo. 188
Effectiveness and efficacy of nutritional therapy: a systematic review following Cochrane methodology 188
Standard operating procedures for ESPEN guidelines and consensus papers 186
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 185
Ghrelin forms in the modulation of energy balance and metabolism 185
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. 182
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 177
Hyperglucagonemia stimulates phenylalanine oxidation in humans. 175
Gender-Specific Association of Desacylated Ghrelin with Subclinical Atherosclerosis in the Metabolic Syndrome 172
Negative association between plasma desacylated Ghrelin and carotid artery intima-media thickness in females with the Metabolic Syndrome 168
Nutritional care is a human right: Translating principles to clinical practice 167
Clinical nutrition university: Muscle physiology and bioenergetics 167
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. 164
Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. 164
Protein metabolism in glucagonoma. 163
Sarcopenic obesity: Time to meet the challenge 163
Perioperative nutritional support. 161
Evidence for acute stimulation of fibrinogen production by glucagon in humans 161
Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. 161
The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study 161
Effects of branched-chain-enriched amino acids and insulin on forearm leucine kinetics. 159
Preserved skeletal muscle mitochondrial function, redox state, inflammation and mass in obese mice with chronic heart failure 159
Differences in estimates of forearm protein synthesis between leucine and phenylalanine tracers following unbalanced amino acid infusion. 158
Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction 157
Postoperative Dehydration Is Associated with Frailty and Decreased Survival in Older Patients with Hip Fracture 157
null 155
Effect of insulin sensitizer therapy on amino acids and their metabolites 155
High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease 154
Double burden of malnutrition in persons with obesity 154
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis 154
Splanchnic amino acid and protein turnover in humans: insight from isotope dilution and catheterization studies. 153
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 152
null 152
Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics. 150
Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans. 149
Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. 149
A year with the GLIM diagnosis of malnutrition - does it work for older persons? 147
Metabolic syndrome and chronic kidney disease. 144
The role of the splanchnic bed in the regulation of amino acid and protein metabolism. 143
Advances in carnitine in chronic uremia 142
Obesity: focus on ongoing multidisciplinary and comprehensive research 141
Totale 37.084
Categoria #
all - tutte 133.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021748 0 0 0 0 0 0 0 0 0 346 121 281
2021/20222.208 75 169 143 167 68 219 93 93 256 250 197 478
2022/20233.117 277 333 222 442 275 550 56 227 356 43 273 63
2023/20244.133 242 157 157 125 169 238 344 396 17 228 974 1.086
2024/202515.579 1.017 1.083 1.370 1.533 1.638 1.406 1.516 1.311 1.977 1.518 655 555
2025/202615.713 1.189 784 1.091 1.310 1.097 1.649 2.746 1.233 2.492 2.122 0 0
Totale 56.154